What does Apotheek Logghe do?

Apotheek Logghe is a pharmacy in Ichtegem. Private Limited, started on 17 March 1987, 1 establishment.

What is the address of Apotheek Logghe?

The registered office of Apotheek Logghe is located at Westkerkestraat(EER) 4, 8480 Ichtegem.

Is Apotheek Logghe still active?

Yes. According to the CBE (30 October 2026) Apotheek Logghe is active, legal situation “Normale toestand”, started on 17 March 1987.

Is Apotheek Logghe registered on Peppol?

Yes, Apotheek Logghe is registered on the Peppol network with ID 0208:0430712365.

What is the enterprise number of Apotheek Logghe?

The enterprise number of Apotheek Logghe is BE0430712365.

When was Apotheek Logghe founded?

Apotheek Logghe was founded on 17 March 1987.

Who are the directors of Apotheek Logghe?

According to the 2025 annual accounts, the directors of Apotheek Logghe are: JUCO CommV, LOGRAM BV.

Is Apotheek Logghe a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 March 1987; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Apotheek Logghe make in 2025?

Apotheek Logghe posted a profit after taxes of € 109,929 in financial year 2025.

What is the revenue of Apotheek Logghe?

As a small company, Apotheek Logghe is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 393,340.

How much does an employee at Apotheek Logghe earn?

The average wage cost per full-time employee at Apotheek Logghe was € 60,700 in 2025: staff costs of € 163,897 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Logghe have?

According to the 2025 annual accounts, Apotheek Logghe has 2.7 full-time equivalents (FTE).

Apotheek Logghe (Private Limited) - Ichtegem

Dossier Apotheek Logghe, printed on 30 October 2026 from databakkes.be/en/0430712365/apotheek-logghe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Logghe from Ichtegem, company number BE0430712365, closed financial year 2025 with a result of € 109,929 after tax. For that financial year Apotheek Logghe recorded a gross margin of € 393,340 and equity of € 914,541. Compared with financial year 2024, the result moved from € 144,761 to € 109,929. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 914,541

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 109,929

▼ 24% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 372,038

▼ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

36 % of the profit went to the shareholders, mostly to LOGRAM (90 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.7

▲ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 163,897

▲ 61% vs 2024

€ 60,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 18 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 256,382

▼ 6% vs 2024

€ 14,486 is repaid this year. At this pace the long-term loan is gone in ≈ 18 years.

Owed to suppliers

€ 228,601

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,248

▲ 121% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 217,360 Gross margin 2022: € 217,360 First fiscal year in the series	€ 311,719 Gross margin 2023: € 311,719 ▲ 43% vs 2022 (€ 217,360) Favourable step	€ 372,891 Gross margin 2024: € 372,891 ▲ 20% vs 2023 (€ 311,719) Favourable step	€ 393,340 Gross margin 2025: € 393,340 ▲ 5% vs 2024 (€ 372,891) Favourable step	▲ 5%
Profit after taxes	€ 76,859 Profit after taxes 2022: € 76,859 First fiscal year in the series	€ 110,081 Profit after taxes 2023: € 110,081 ▲ 43% vs 2022 (€ 76,859) Favourable step	€ 144,761 Profit after taxes 2024: € 144,761 ▲ 32% vs 2023 (€ 110,081) Favourable step	€ 109,929 Profit after taxes 2025: € 109,929 ▼ 24% vs 2024 (€ 144,761) Unfavourable step	▼ 24%
Equity	€ 649,769 Equity 2022: € 649,769 First fiscal year in the series	€ 729,851 Equity 2023: € 729,851 ▲ 12% vs 2022 (€ 649,769) Favourable step	€ 844,612 Equity 2024: € 844,612 ▲ 16% vs 2023 (€ 729,851) Favourable step	€ 914,541 Equity 2025: € 914,541 ▲ 8% vs 2024 (€ 844,612) Favourable step	▲ 8%
Total debts	€ 678,956 Total debts 2022: € 678,956 First fiscal year in the series	€ 763,386 Total debts 2023: € 763,386 ▲ 12% vs 2022 (€ 678,956) Unfavourable step	€ 754,736 Total debts 2024: € 754,736 ▼ 1% vs 2023 (€ 763,386) Favourable step	€ 561,571 Total debts 2025: € 561,571 ▼ 26% vs 2024 (€ 754,736) Favourable step	▼ 26%
Cash	€ 277,535 Cash 2022: € 277,535 First fiscal year in the series	€ 271,621 Cash 2023: € 271,621 ▼ 2% vs 2022 (€ 277,535) Unfavourable step	€ 477,766 Cash 2024: € 477,766 ▲ 76% vs 2023 (€ 271,621) Favourable step	€ 372,038 Cash 2025: € 372,038 ▼ 22% vs 2024 (€ 477,766) Unfavourable step	▼ 22%
Land & buildings	€ 374,844 Land & buildings 2022: € 374,844 First fiscal year in the series	€ 345,221 Land & buildings 2023: € 345,221 ▼ 8% vs 2022 (€ 374,844) Unchanged	€ 315,599 Land & buildings 2024: € 315,599 ▼ 9% vs 2023 (€ 345,221) Unchanged	€ 294,255 Land & buildings 2025: € 294,255 ▼ 7% vs 2024 (€ 315,599) Unchanged	▼ 7%
Retained profit	€ 631,177 Retained profit 2022: € 631,177 First fiscal year in the series	€ 711,259 Retained profit 2023: € 711,259 ▲ 13% vs 2022 (€ 631,177) Favourable step	€ 826,020 Retained profit 2024: € 826,020 ▲ 16% vs 2023 (€ 711,259) Favourable step	€ 895,949 Retained profit 2025: € 895,949 ▲ 8% vs 2024 (€ 826,020) Favourable step	▲ 8%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 30,000 Dividend 2023: € 30,000 Unchanged (€ 0) Unchanged	€ 30,000 Dividend 2024: € 30,000 Unchanged (€ 30,000) Unchanged	€ 40,000 Dividend 2025: € 40,000 ▲ 33% vs 2024 (€ 30,000) Unchanged	▲ 33%
Bank debt	€ 399,048 Bank debt 2022: € 399,048 First fiscal year in the series	€ 284,320 Bank debt 2023: € 284,320 ▼ 29% vs 2022 (€ 399,048) Favourable step	€ 271,800 Bank debt 2024: € 271,800 ▼ 4% vs 2023 (€ 284,320) Favourable step	€ 256,382 Bank debt 2025: € 256,382 ▼ 6% vs 2024 (€ 271,800) Favourable step	▼ 6%
Balance sheet total	€ 1,328,725 Balance sheet total 2022: € 1,328,725 First fiscal year in the series	€ 1,493,237 Balance sheet total 2023: € 1,493,237 ▲ 12% vs 2022 (€ 1,328,725) Unchanged	€ 1,599,348 Balance sheet total 2024: € 1,599,348 ▲ 7% vs 2023 (€ 1,493,237) Unchanged	€ 1,476,112 Balance sheet total 2025: € 1,476,112 ▼ 8% vs 2024 (€ 1,599,348) Unchanged	▼ 8%
Employees (FTE)	1.8 Employees (FTE) 2022: 1.8 First fiscal year in the series	1.8 Employees (FTE) 2023: 1.8 Unchanged (1.8) Unchanged	1.9 Employees (FTE) 2024: 1.9 ▲ 0.1 vs 2023 (1.8) Unchanged	2.7 Employees (FTE) 2025: 2.7 ▲ 0.8 vs 2024 (1.9) Unchanged	▲ 0.8

Key figures of Apotheek Logghe, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Logghe?

What happened at Apotheek Logghe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 109,929 (▼ 24% vs 2024). Source: NBB ↗
2022 JUCO CommV became a director. NBB
2022 LOGRAM BV became a director. NBB
Apr 14, 1987 New establishment in Ichtegem. KBO
Mar 17, 1987 Start of the company according to the CBE. KBO

In short

From € 76,859 profit in 2022 to € 109,929 profit in 2025.

Paid € 90,719 in corporate taxes since 2022.

Best year ever: 2024, with € 144,761 profit.

On average € 145,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

LOGRAM 90%

The stake of LOGRAM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Logghe

Behind Apotheek Logghe are JUCO CommV and LOGRAM BV. The shares are held by LOGRAM (90%).

Directors

According to the 2025 annual accounts

JUCO CommV

Director · represented by Justine COOLMAN

since 2022

LOGRAM BV

Director · represented by Martijn LOGGHE

since 2022

Shareholders

LOGRAM

90%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Westkerkestraat(EER) 4

8480 Ichtegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Apotheek Becue

LOGRAM same network

€ 212,563 gross margin · 2025

Juco same network

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0430.712.365

VAT number

BE 0430.712.365

Registered office

Westkerkestraat(EER) 4, 8480 Ichtegem

Names & denominations

Apotheek Logghe

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 March 1987

Peppol

Active · Active since 26 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Logghe

Financials

What happened to Apotheek Logghe?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions